LIVE Symposium

Thursday, December 12, 2024
1:00 PM-4:00 PM ET (10:00 AM-1:00 PM PT)

As next-generation sequencing becomes more accessible, scientists gain unprecedented resolution to explore the underpinnings of health and disease. The information they have obtained has revolutionized how rare diseases and cancers are understood.

In this virtual symposium brought to you by The Scientist, an expert panel will explore the NGS platforms and complementary omics technologies essential for rare disease research. The panel will also discuss the lessons researchers continue to learn about rare diseases and more common disorders such as cancer from sequencing-powered data.

Symposium program

1:00 PM – Introduction

1:10 PM- Empowering Discovery with Automated Total RNA and WGA Sequencing

Yue Yun, PhD

1:40 PM – Deciphering Genetic and Non-Genetic Drivers of Cancer via Single Cell Multi-omics

Anna Nam, MD

2:10 PM – Leveraging NGS for Uncovering Rare Disease Mechanisms

Anupriya Dalmia, PhD  

2:40 PM - Pinpointing causal noncoding variants using massively-parallel single-cell CRISPR screens

Neville Sanjana, PhD

3:10 PM – TBD

Laura Huckins, PhD

3:40 PM - Open panel Q&A session
Nathan Ni from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.


Yun

Yue Yun, PhD
R&D Director, NGS
Takara Bio USA, Inc.

Nam

Anna Nam, MD
Assistant Professor
Pathology and Laboratory Medicine
Weill Cornell Medicine

Dalmia

Anupriya Dalmia, PhD
Senior Researcher
UK Dementia Research Institute
University College London

Neville

Neville Sanjana, PhD
Core Faculty Member
New York Genome Center
Associate Professor of Biology
Neuroscience and Physiology
New York University

headshot

Laura Huckins, PhD
Associate Professor 
Psychiatry
Yale University


Gold Sponsor


Takara Bio